Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Explainable Artificial Intelligence For Diagnostics Market Size Forecast: How Large Could The Market Become By 2030?
The market for artificial intelligence that provides diagnostic explanations has experienced a significant surge recently. Projections indicate a substantial increase from $1.69 billion in 2025 to $2.12 billion in 2026, reflecting a compound annual growth rate (CAGR) of 25.9%. This expansion during the past period is largely due to the wider acceptance of AI-driven diagnostic technologies, the development of digital health infrastructure, the increasing volume of medical imaging data, a growing need for systems that support clinical decisions, and the establishment of initial regulatory guidelines for AI in the healthcare sector.
The market for AI that clarifies diagnostic processes is poised for significant expansion, projected to reach $5.28 billion by 2030, which represents a compound annual growth rate of 25.6%. This anticipated surge is fueled by several key factors, including a greater number of regulations requiring transparent AI systems, increased funding for reliable AI technologies, the broadening use of explainable AI beyond visual analysis, a stronger desire from healthcare professionals for understandable results, and the deeper incorporation of AI into electronic health records. Over this same period, primary trends will involve the wider acceptance of AI diagnostic tools that offer clear explanations, the incorporation of explainability features into clinical AI software, a heightened focus on AI systems that adhere to regulatory standards, the expanded application of AI in diagnosing conditions using multiple data types, and an elevated importance placed on building clinical confidence and transparency in AI.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28216&type=smp
Explainable Artificial Intelligence For Diagnostics Market Expansion Supported By Key Demand Factors
The accelerating pursuit of individualized medical care is projected to be a significant catalyst for the expansion of the explainable artificial intelligence in diagnostics sector. This approach to healthcare, known as personalized medicine, involves tailoring preventative strategies, diagnostic procedures, and therapeutic interventions to an individual’s unique genetic makeup, lifestyle choices, and environmental factors. The rise of personalized medicine is fueled by continuous advancements in genomic data analysis and sequencing technologies, which facilitate the development of more precise, targeted, and efficacious treatments specifically designed for individual patients. Explainable AI plays a crucial role in realizing personalized medicine by offering clear, understandable interpretations of patient-specific information, thereby informing and guiding customized treatment choices. To illustrate, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit entity, the Food and Drug Administration authorized 16 novel personalized therapies for individuals suffering from rare diseases in 2023, a considerable increase from the six approvals seen in 2022. Additionally, the personalized treatments greenlit in 2023 encompassed seven drugs for oncological conditions and three for various other ailments. Consequently, the escalating need for personalized medicine is directly contributing to the growth trajectory of the market for explainable AI in diagnostics.
Explainable Artificial Intelligence For Diagnostics Market Segment Outlook: Which Categories Are Expanding The Fastest?
The explainable artificial intelligence for diagnostics market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud
3) By Application: Medical Imaging, Pathology, Genomics, Risk Assessment, Treatment Recommendation, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Clinics, Other End-Users
Subsegments:
1) By Software: Machine Learning Platforms, Natural Language Processing Tools, Computer Vision Tools
2) By Hardware: Imaging Devices, Computational Devices, Sensors And Scanners
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education
Explainable Artificial Intelligence For Diagnostics Market Growth Trends Influencing Competitive Dynamics
Leading entities within the explainable artificial intelligence for diagnostics sector are prioritizing the creation of sophisticated methodologies, exemplified by the AI-driven HER2 scoring algorithm, to elevate diagnostic precision, foster transparent decision frameworks, and facilitate individualized cancer therapies. This AI-driven HER2 scoring algorithm is essentially a machine learning construct engineered to process medical imagery, like that of breast cancer tissue specimens, for the automatic evaluation of HER2 protein expression levels, thereby yielding precise, uniform, and comprehensible outcomes to inform diagnostic processes and tailored therapeutic choices. As a case in point, PathAI Inc., an American firm specializing in AI-driven digital pathology, introduced AIM-HER2 Breast Cancer in July 2023, a solution intended to refine the accurate identification of HER2 status among breast cancer patients. This innovation provides autonomous, consistent HER2 scoring complemented by explainable AI heatmaps that pinpoint crucial tissue attributes, thereby bolstering diagnostic assurance and clarity throughout the diagnostic process. Its capacity to examine entire breast cancer biopsy slides, circumventing the need for manual area selection, significantly optimizes the workflow for pathologists, proving particularly beneficial in complex borderline scenarios. The overarching objective of this AI-powered instrument is to augment accuracy, enhance operational efficiency, and cultivate greater confidence in HER2 scoring procedures utilized within biopharmaceutical research and clinical laboratory settings.
Explainable Artificial Intelligence For Diagnostics Market Key Companies And Competitive Benchmarking
Major companies operating in the explainable artificial intelligence for diagnostics market are Fujitsu Limited, Koninklijke Philips N.V., Tempus AI, Owkin Inc., PathAI Inc., Aidoc Medical Ltd., Viz.ai Inc., Qure.ai Technologies Private Limited, Paige.AI Inc., Digital Diagnostics Inc., Enlitic, Aignostics GmbH, Proscia Inc., Corti ApS, Fiddler AI Inc., Riverain Technologies LLC, Arthur AI Inc., InData Labs, Ibex Medical Analytics Ltd., Mindpeak GmbH, Therapixel SAS.
Access The Complete Explainable Artificial Intelligence For Diagnostics Market Report:
Explainable Artificial Intelligence For Diagnostics Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the explainable artificial intelligence for diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the explainable artificial intelligence for diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
